Topical antibiotics for blepharitis

Article

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Related Content
Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary end point - Image credit: ©patpitchaya—stock.adobe.com

Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary end point

Martin David Harp, Editor, Ophthalmology Times
July 23rd 2025
Article
Image Credit: © ohishift - stock.adobe.com

Safety, efficacy of lotilaner ophthalmic solution for Demodex blepharitis treatment

Lynda Charters
March 31st 2023
Article
SECO 2023: Drugs of the future

SECO 2023: Drugs of the future

Milton M. Hom, OD, FAAO, FACAAI (Sc);Emily Kaiser Maharjan, Assistant Managing Editor;Kassi Filkins, Editor
March 2nd 2023
Article
Eye care therapies on the move: What’s in the pipeline

Eye care therapies on the move: What’s in the pipeline

Lynda Charters
September 16th 2022
Article
Effective treatments for presbyopia, myopia, demodex

Effective treatments for presbyopia, myopia, demodex

Lynda Charters
March 12th 2022
Article
Protect patients’ eyes by encouraging a three-step ocular wellness regimen

Protect patients’ eyes by encouraging a three-step ocular wellness regimen

Whitney Hauser, OD
October 9th 2020
Article
© 2025 MJH Life Sciences

All rights reserved.